| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261183.1 |
Gefitinib |
Breast invasive carcinoma |
0.00121945 |
Sensitive |
| ENSG00000261183.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.049416875 |
Sensitive |
| ENSG00000261183.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.000832562 |
Sensitive |
